Robert Freedman, MD
VA Eastern Colorado Health Care System, Denver, CO · University of Colorado, Denver · U of Colorado Denver
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Robert Freedman, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:03 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT02538081 · Nicotinic Receptors and SchizophreniaVA Office of Research and Development · withdrawn · Schizophrenia · principal investigator
- Ph1NCT02111551 · Phase I Nicotinic Agonist Treatment Trial for AutismUniversity of Colorado, Denver · terminated · Autism · principal investigator
- Ph1/Ph2NCT01905605 · Phosphatidylcholine Supplementation in InfantsUniversity of Colorado, Denver · withdrawn · Schizophrenia, Diminished P50 Sensory Gating · principal investigator
- Ph1NCT01851603 · Phase I Study to Evaluate the Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 in Healthy SubjectsUniversity of Colorado, Denver · terminated · Schizophrenia · principal investigator
- Ph2NCT01400477 · Nicotinic Receptors and SchizophreniaUniversity of Colorado, Denver · completed · Schizophrenia, Schizoaffective Disorder · principal investigator
- Ph1NCT00952393 · Nicotinic Receptors and SchizophreniaVA Office of Research and Development · completed · Schizophrenia · principal investigator
- Ph1NCT00332124 · Safety and Effectiveness of Taking Choline Supplements During Pregnancy for Improving Infant Brain DevelopmentUniversity of Colorado, Denver · completed · Pregnancy, Child Development · principal investigator
- Ph1NCT00255918 · Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia PatientsUniversity of Colorado, Denver · completed · Schizophrenia, Psychotic Disorders · principal investigator
- N/ANCT00108303 · Genetic Research in Schizophrenia Using DNA Markers and Clinical PhenotypesVA Office of Research and Development · completed · Schizophrenia · principal investigator
- Ph2NCT00100165 · Phase 2 Trial of a Nicotinic Agonist in SchizophreniaUniversity of Colorado, Denver · completed · Schizophrenia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:03 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 5 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- EMOTIONAL SIGNALING IN INFANCYK05MH036808 · NIMH · UNIVERSITY OF COLORADO DENVER · fiscal years 1985 to 1997 · $96,945 awarded in 1997Same name and institution; not confirmed by an ID
- SOCIAL AFFECTIVE DEVELOPMENT IN INFANCYR37MH022803 · NIMH · UNIVERSITY OF COLORADO DENVER · fiscal years 1988 to 1997 · $271,614 awarded in 1997Same name and institution; not confirmed by an ID
- SOCIAL AFFECTIVE DEVELOPMENT IN INFANCYR01MH022803 · NIMH · UNIVERSITY OF COLORADO DENVER · fiscal years 1985 to 1987 · $34,245 awarded in 1987Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Human Trial of Allosteric Modulator Alpha7 Nicotinic Receptors in SchizophreniaU01MH094247 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI JOSHUA Tolkien KANTROWITZ, JEFFREY A. LIEBERMAN · fiscal years 2011 to 2015Named on NCT01851603
- MOUSE MOLECULAR AND NEUROBIOLOGICAL MODELSP50MH086383 · NIMH · UNIVERSITY OF COLORADO DENVER · PI ROBERT R FREEDMAN · fiscal years 2009 to 2013Named on NCT01400477
- Nicotinic Agonist in SchizophreniaR01MH061412 · NIMH · UNIVERSITY OF COLORADO DENVER · PI Robert Freedman · fiscal years 2001 to 2010Named on NCT01400477, NCT00255918
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.